News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 73–108
- Matches
- 3492
- Sources here
- 20
- Companies here
- 25
Active search
3492 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Insider Selling: Arista Networks (NYSE:ANET) CEO Sells 573,509 Shares
Arista Networks CEO Jayshree Ullal sold 573,509 shares of the company's stock for approximately $119.4 million, significantly reducing her direct holdings. This transaction was part of a pre-arranged trading plan, following several other large sales in recent months. Despite the insider selling, Arista Networks …
Arista Networks (ANET) family trusts sell 573,509 shares under 10b5-1 plan
Trusts associated with Arista Networks CEO and Chairperson Jayshree Ullal sold a total of 573,509 shares of common stock on August 12, 2026. These indirect sales, made under a Rule 10b5-1 trading plan, occurred at weighted average prices ranging from $207.00 to $211.37 per …
Arista Networks (NYSE:ANET) Trading Down 2.3% - Should You Sell?
Arista Networks (NYSE:ANET) shares dropped 2.3% in mid-day trading despite strong quarterly results that beat analyst estimates for EPS and revenue, with 37.7% year-over-year revenue growth. Analysts maintain a "Buy" rating with a consensus target of $226.05, with some firms recently raising their targets. …
Arista Networks (ANET) Is Up 5.9% After AI-Fueled Q3 Revenue Guidance Upgrade - Has The Bull Case Changed?
In the past week, Arista Networks reported second-quarter 2026 results showing revenue of US$3.04 billion and net income of US$1.21 billion, alongside guidance for roughly US$3.30 billion in third-quarter revenue. Management linked this stronger outlook to accelerating demand for AI-driven network deployments, underscoring how …
Sharemaestro market context Trend signal active 52 weeks +36.9%Analysts Have Made A Financial Statement On DarioHealth Corp.'s (NASDAQ:DRIO) Second-Quarter Report
DarioHealth Corp. (NASDAQ:DRIO) recently reported its second-quarter results, showing a revenue miss but a smaller-than-expected per-share loss. Analysts have since revised their forecasts, significantly cutting revenue expectations for 2026 while also reducing estimated losses. Despite these adjustments, the consensus price target remains largely unchanged, …
Arista Networks vs. AppLovin: Which Technology Stock Is a Better Buy in 2026?
This article compares Arista Networks (ANET) and International Business Machines (IBM) as potential technology stock investments in 2026, analyzing their business models, financial performance, risk profiles, and valuations. While Arista Networks operates in data center hardware with high growth and margins but customer concentration, …
Arista Networks vs. AppLovin: Which High-Growth Tech Stock Deserves Your Capital in 2026?
This article compares Arista Networks and AppLovin as high-growth tech stock investment opportunities in 2026, highlighting their differing approaches to the AI boom. Arista Networks offers stability and strong cash flow through data center infrastructure, despite customer concentration risks. AppLovin, while showing higher growth …
Royal Caribbean Group stock underperforms Friday when compared to competitors
Royal Caribbean Group (RCL) stock fell by 1.57% on Friday, closing at $305.00, despite a two-day winning streak. This underperformance occurred on a generally negative trading day for the stock market, with both the S&P 500 Index and Dow Jones Industrial Average also declining. …
Caribou Biosciences, Inc. (NASDAQ:CRBU) Receives Consensus Rating of "Moderate Buy" from Analysts
Caribou Biosciences (NASDAQ:CRBU) has received a consensus "Moderate Buy" rating from analysts, with an average 12-month price target of $7.75. The company's shares recently traded down 2.2% to $1.57. Caribou Biosciences reported a narrower-than-expected quarterly loss but missed revenue estimates, and institutional investors own …
Caribou Biosciences earnings beat by $0.07, revenue topped estimates
Caribou Biosciences (NASDAQ: CRBU) reported second-quarter EPS of $-0.240, beating analyst estimates by $0.07, and revenue of $2.65 million, surpassing the consensus estimate of $2.3 million. Despite the earnings beat, the company's stock price has declined by -24.770% in the last three months and …
Arista Networks Inc. stock underperforms Friday when compared to competitors
Shares of Arista Networks Inc. (ANET) fell 2.36% on Friday, closing at $198.82, underperforming the broader market. This decline occurred during a poor trading session where the S&P 500 Index dropped 0.17% and the Dow Jones Industrial Average fell 0.20%. This marks the second …
Solaris Energy Infrastructure (SEI): Yorktown group reports 7.2% beneficial stake
Yorktown Energy Partners X and its affiliates have filed an amended Schedule 13G, reporting a 7.2% beneficial ownership stake in Solaris Energy Infrastructure, Inc. This stake comprises 5,079,234 Solaris LLC Units and corresponding Class B common shares, exchangeable into Class A shares. The beneficial …
CLVT|Clarivate PLC|Price:1.923|Chg%:-0.037
This article provides a detailed overview of Clarivate PLC (CLVT) stock, including its current price, market capitalization, key financial figures, and recent performance. It also covers analyst ratings, a technical analysis summary, company profile, and major shareholders. The stock's current rating is "Hold" with …
Akari Therapeutics targets mid-2027 phase 1 trial for AKTX-101
Akari Therapeutics reported its Q2 2026 financial results, including raising $8.6 million in gross proceeds. The company announced plans to initiate a Phase 1 clinical trial for its lead antibody drug conjugate candidate, AKTX-101, by mid-2027. AKTX-101 utilizes a proprietary PH1 payload targeting RNA …
MLM6482399 Bond Coupon Profile — Rate & Payments
This article provides a coupon profile for the Martin Marietta Materials, Inc. bond MLM6482399, which has a 4.85% interest rate and matures on August 15, 2029. It details that the next interest payment is scheduled for February 16, 2027, and offers an overview of …
Grupo Aeroportuario Del Pacifico (NYSE:PAC) Hits New 1-Year Low - Here's What Happened
Grupo Aeroportuario Del Pacifico (NYSE:PAC) recently hit a new 52-week low of $206.61, trading below its 50-day and 200-day moving averages. The company missed its quarterly earnings and revenue estimates, reporting $2.80 EPS against an estimated $3.10 and $645.23 million in revenue versus a …
Sharemaestro market context Price below Trend Line 52 weeks -16.2%HSBC Stock And 2 Global Bank Picks for Trade and Rate Rule Changes
This article identifies three global banking stocks—Banco Bilbao Vizcaya Argentaria (BBVA), Banco Santander (SAN), and HSBC Holdings (HSBA)—that are well-positioned to navigate the evolving landscape of trade, interest rates, and compliance regulations. These banks offer diversified operations, significant digital banking investments, and varying risk-reward …
MLM6481685 Bond Coupon Profile — Rate & Payments
This article provides a coupon profile for the Martin Marietta Materials, Inc. bond, identified as MLM6481685. It details the bond's interest payment overview, stating a current coupon rate of 5.20% and a next payment planned for February 1, 2027. The content focuses on the …
Citi Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $8
Citi has reiterated its Buy rating for Caribou Biosciences (CRBU.US) and maintained its target price at $8. This indicates the firm's continued positive outlook on the company's stock performance.
MLM6481685 Latest News and Headlines
This page provides news and headlines for the corporate bond MLM6481685, which belongs to Martin Marietta Materials, Inc. The bond has a 5.2% interest rate and matures on January 30, 2032. The page also indicates that market data is provided by ICE Data Services …
The Bull Case For Royal Caribbean Cruises (RCL) Could Change Following New 2034 Bond Sale And Profit Upgrade
Royal Caribbean Cruises (RCL) recently issued US$1.25 billion in 2034 senior unsecured notes shortly after raising its full-year profit outlook due to strong demand. This move indicates the company's willingness to use debt markets to fund growth, reinforcing the importance of sustained cruising appeal …
Vesta: Undervalued In The Long-Term With Sights On Portfolio Growth (NYSE:VTMX)
Corporación Inmobiliaria Vesta (VTMX) is considered undervalued with a significant upside potential of 245.73% by 2030, driven by its expanding industrial portfolio and projected rental income growth. While the company's FFO per share is expected to increase substantially due to nearshoring and portfolio expansion, …
Caribou Biosciences, Inc. Stock 12‑Month Price Target Cut to $11.86, Implies 636% Upside
Analysts have cut the 12-month average price target for Caribou Biosciences, Inc. stock from $12 to $11.86, with individual forecasts ranging from $4 to $32 per share. Despite the slight reduction in the average target, this still implies a significant 636% potential upside based …
Navios Maritime Partners (NMM) Q1 2024 Earnings Report - Results, Call & Slides
Navios Maritime Partners (NMM) reported strong Q1 2024 earnings, beating analyst expectations with an actual EPS of $2.32 against a consensus of $2.01, and revenue of $318.56 million against an expected $283.59 million. This marks a 2.92% year-over-year revenue growth. The company has also …